Clinical Trials Directory

Trials / Completed

CompletedNCT04794608

Hypnosis in Virtual Reality in Patients in Protector Isolation Room for Aplasia in Clinical Hematology.

Hypnosis in Virtual Reality in Patients in Protector Isolation Room for Aplasia in Clinical Hematology. Monocentric, Comparative, Randomized, Open Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hôpital Privé Sévigné · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hematology patients are frequently treated in hospital for aplasia. Patients are then placed in protective isolation room. This situation of protective isolation can represent a significant source of stress and anxiety for the patient. Hypnosis is already used to treat anxiety in patients with cancer. The purpose of this study is to evaluate the impact of virtual reality medical hypnosis sessions on anxiety and chronic pain of patients hospitalized for aplasia in order to broaden the supportive care proposals in the clinical hematology service of Sévigné Private Hospital.

Detailed description

After verifying the patient's eligibility criteria and obtaining the signed informed consent form, the patient is randomized to the arm receiving hypnosis in virtual reality or to the control arm. The study ends after three consecutive days in protector isolation with one session hypnosis in virtual reality per day.

Conditions

Interventions

TypeNameDescription
DEVICEHYPNO VR® deviceThe HYPNO VR® device is a software application of medical hypnosis in the treatment of pain and anxiety. It is associated with equipment: a virtual reality headset and a headphone. Before each session of hypnosis, the nursing staff offers patients the choices: visual universe, musical theme, male or female voice. The nursing staff selects the program, selects a duration of 20 minutes and presses start to start the medical hypnosis session in virtual reality. After completing the hypnotic trance sequence, as in a classic session, the patient is brought back to the "return" and exit hypnosis phase under the supervision of the nursing staff.

Timeline

Start date
2021-06-17
Primary completion
2024-01-30
Completion
2024-02-28
First posted
2021-03-12
Last updated
2025-02-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04794608. Inclusion in this directory is not an endorsement.

Hypnosis in Virtual Reality in Patients in Protector Isolation Room for Aplasia in Clinical Hematology. (NCT04794608) · Clinical Trials Directory